Institute for Integrative Medicine, University of Witten/Herdecke, Gerhard-Kienle-Weg 4, 58313 Herdecke, Germany; Crystal Lab, Landgoed Roepaen, Kleefseweg 9, 6595 NK Ottersum, the Netherlands.
Biodynamic Research Association Denmark, Landsbyvaenget 7, Herskind, 8464 Galten, Denmark.
Eur J Pharm Sci. 2019 Sep 1;137:104987. doi: 10.1016/j.ejps.2019.104987. Epub 2019 Jul 8.
According to the European Pharmacopoeia monograph 1038 (Praeparationes homoeopathicae), homeopathic preparations are produced by successive dilution and succussion steps. Dilution levels beyond Avogadro's limit, however, render specific effects implausible according to standard scientific knowledge. Accordingly, we were interested in a critical empirical investigation of preparations produced according to this monograph. Within a precursor study we developed a bioassay based on a fingerprint metabolomic analysis of Lepidium sativum seeds germinated in vitro in either homeopathic preparations or controls in a blinded and randomized assignment. Results of the precursor study were not consistent with the hypothesis that the effects of a Stannum metallicum 30x preparation are identical to placebo. In the present study we investigated the reproducibility of these effects after scrutinizing and optimizing experimental procedures. Ten independent experiments were performed in a blinded and randomized assignment in two independent laboratories. Additionally, 10 systematic negative water control experiments were performed in both laboratories to critically assess the stability of the experimental set-up. The effects of the Stannum metallicum 30x treatment were reproduced. The systematic negative control experiments did not yield false-positive results, indicating a stable experimental set-up. We thus repeatedly observed biological effects conflicting with the assumption that Stannum metallicum 30x is identical to placebo. We therefore wish to discuss whether these findings are to be considered a scientific anomaly or whether they might stimulate further investigations to clarify whether application of the European Pharmacopoeia monograph 1038 may result in pharmaceutical preparations with specific effects.
根据欧洲药典专论 1038(顺势疗法制剂),顺势疗法制剂是通过连续稀释和摇动步骤生产的。然而,根据标准科学知识,超过阿伏伽德罗极限的稀释水平使得特定效果变得不可信。因此,我们有兴趣对根据该专论生产的制剂进行批判性的实证研究。在一项前期研究中,我们开发了一种基于指纹代谢组学分析的生物测定法,该分析是对在体外发芽的 Lepidium sativum 种子进行的,这些种子要么在顺势疗法制剂中,要么在对照物中,采用盲法和随机分配。前期研究的结果与以下假设不一致:Stannum metallicum 30x 制剂的作用与安慰剂相同。在本研究中,我们在仔细检查和优化实验程序后,研究了这些效果的重现性。在两个独立的实验室中,以盲法和随机分配的方式进行了 10 次独立实验。此外,在两个实验室中进行了 10 次系统的阴性水对照实验,以批判性地评估实验设置的稳定性。Stannum metallicum 30x 处理的效果得到了重现。系统的阴性对照实验没有产生假阳性结果,表明实验设置稳定。因此,我们反复观察到与假设相反的生物学效应,即 Stannum metallicum 30x 与安慰剂相同。因此,我们希望讨论这些发现是否应被视为科学异常,或者它们是否可能激发进一步的研究,以澄清应用欧洲药典专论 1038 可能导致具有特定效果的药物制剂。